Qmx Pharma Llp - Due diligence report
A 360° intelligence report on Qmx Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signals…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Qmx Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsQmx Pharma Llp is assessed as Low Risk with a Trust Score of 86/100. Qmx Pharma Llp is an active limited liability partnership incorporated in 2022, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 14 Oct 2026 from the latest processed filings. Qmx Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- No balance-sheet filing date on record.
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| LALITHA AMIDHEPURAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUDHEER AMIDHEPURAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 3 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Brain Morph Technologies Private Limited | U62099TS2025PTC193640 | Medak, Telangana |
| Finewin Private Limited | U72900TG2020PTC145746 | Medak, Telangana |
| SETDAM INFO LABS LLP | AAL-4597 | Medak, Telangana |
| Chesan It Solutions Private Limited | U62091TS2024PTC184855 | Medak, Telangana |
| Aliens Hills Private Limited | U45400TG2007PTC056822 | Medak, Telangana |
| E Embedded Ai Technologies Private Limited | U72900TG2021PTC156055 | Medak, Telangana |
| Areolus Developers Private Limited | U70109TG2022PTC169805 | Medak, Telangana |
| VN AQUA SOLUTIONS LLP | ABC-8139 | Medak, Telangana |
| Maargvani It Solutions Private Limited | U72900TG2022PTC158693 | Medak, Telangana |
| Gss Ndt Solutions (Opc) Private Limited | U74999TG2019OPC130735 | Medak, Telangana |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Qmx Pharma Llp before audits and certifications: compliance score 90/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Qmx Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Qmx Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Qmx Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Qmx Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Qmx Pharma Llp an active company?
Qmx Pharma Llp has MCA status “Active” with a compliance score of 90/100 (Low Risk).
Is Qmx Pharma Llp financially healthy?
Processed financial statements are not yet available for Qmx Pharma Llp, so its financial health is unassessed.
Should I do business with Qmx Pharma Llp?
Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Qmx Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Qmx Pharma Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Qmx Pharma Llp up to date with its ROC filings?
No balance-sheet filing date on record. Overall compliance score: 90/100 (Low Risk).
Is it risky to lend to Qmx Pharma Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.